Creating a tool to predict treatment outcomes for suicidal service members
Official title: Development of a Treatment Prognosis Calculator for the Prevention of Suicide
Run by Ohio State University · NCT06094218 · Data updated 2026-11-12
This study is testing a new tool to help figure out which military personnel struggling with suicidal thoughts will do better with regular treatment or a special therapy called Brief Cognitive Behavioral Therapy.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 1200 (estimated) |
| Sponsor | Ohio State University Academic / other |
| Locations | 1 site (Columbus, Ohio) |
| Status | Recruiting |
| Started | October 31, 2026 |
| Main results expected | October 31, 2028 |
| Study ends | August 31, 2029 |
| Registry record updated | October 16, 2026 |
| Trial ID | NCT06094218 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are active duty service members aged 18 and older who are currently engaged in mental health treatment and exhibit suicidal ideation.
✕Probably not a fit
Patients with psychiatric or medical conditions that prevent informed consent or participation in treatments, such as psychosis or acute intoxication, may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study aims to develop and test a treatment prognosis calculator designed to identify military personnel with suicidal ideation who are likely to respond to standard care versus those who would benefit more from Brief Cognitive Behavioral Therapy (BCBT). The study will involve active duty service members engaged in mental health treatment, assessing their responses to treatment as usual (TAU) and comparing it to BCBT for those predicted to have inadequate responses to TAU. The ultimate goal is to enhance treatment effectiveness and reduce suicidal ideation among service members.
Why it matters
Potential benefit: If successful, this tool could significantly improve treatment outcomes for service members experiencing suicidal thoughts by personalizing their care.
How similar studies have gone: While the approach of developing a treatment prognosis calculator is innovative, similar studies focusing on personalized treatment for suicidal ideation have shown promise in improving outcomes.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. female and male active duty service members; 2. =\> 18 years old; 3. engaged in mental health treatment at one of the sites at study enrollment; 4. score \>0 on the Columbia Suicide Severity Rating Scale (CSSRS) Screener-Recent, or indicated suicidal ideation on questions 4 or 5 of the Scale for Suicidal Ideation, indicating suicidal ideation within the last month; 5. able to understand and speak English; 6. able to provide consent. Exclusion Criteria: (1) participants with a psychiatric or medical condition that prevents them from providing informed consent or from participating in the treatments (e.g., psychosis, mania, acute intoxication).
Where it's running
-
Harding Hospital
Columbus, Ohio, United States Recruiting
Study contacts
- Study coordinator: Jay Fournier, PhD
- Email: jay.fournier@osumc.edu
- Phone: 614-293-9889
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Multi-layered digital monitoring and pharmacogenomics to prevent suicide in adults with depression
This study tests whether a digital monitoring system, a digital safety plan, and pharmacogenetic-guided care can reduce suicide re-attempts in adults with depression.
-
Rapid relief of suicidal thoughts with ketamine and a crisis plan in the emergency department
This study tests whether a single intramuscular dose of ketamine plus a brief Crisis Response Plan helps reduce suicidal thoughts in ED patients who are likely to be admitted.
-
Recovery-oriented suicide prevention for young people at clinical high risk for psychosis
This program tests a peer-supported, clinician-led suicide prevention group for young people at clinical high risk for psychosis to see if it helps reduce suicidal thoughts and support recovery.
-
Reward Sensitivity Digital App for Adolescent Suicidal Thoughts
A smartphone app is tested in teens to see if daily check-ins and mood-building activities can reduce suicidal thoughts and improve mood.
-
Student Precarity and Psychiatry: How Financial Struggles Relate to Depression and Loneliness
This observational study looks at whether financial hardship and social isolation are linked to depression, suicidal thoughts, and loneliness among French university students.
-
Ketamine with DBT for suicidality in adults with treatment-resistant depression or bipolar disorder and BPD
This study tests whether four ketamine infusions plus Dialectical Behavioural Therapy can more quickly reduce suicidal thoughts in adults with Borderline Personality Disorder and treatment-resistant depression or bipolar disorder.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.